Stockholder's Equity (Details) - USD ($)
|
|
|
|
|
|
3 Months Ended |
12 Months Ended |
|
|
|
|
|
Dec. 10, 2025 |
Dec. 08, 2025 |
Sep. 19, 2025 |
Sep. 10, 2025 |
Jul. 17, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Oct. 27, 2025 |
Apr. 07, 2025 |
Aug. 05, 2024 |
Aug. 02, 2024 |
Apr. 29, 2023 |
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
400,000,000
|
|
400,000,000
|
100,000,000
|
|
|
110,000,000
|
|
|
| Common stock par value (in Dollars per share) |
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
| Preferred stock authorized |
|
|
|
|
|
10,000,000
|
|
10,000,000
|
10,000,000
|
|
|
|
|
|
| Preferred stock par value (in Dollars per share) |
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
| Gross proceeds offering (in Dollars) |
|
|
|
|
$ 7,546,988
|
|
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
|
7,546,988
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
905,000
|
|
|
|
|
|
|
|
|
|
| Expenses of placement agent fee (in Dollars) |
|
|
|
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
| Common stock per share (in Dollars per share) |
|
|
|
$ 1.75
|
|
|
|
|
|
|
|
|
|
|
| Aggregate shares of common stock |
|
|
|
|
|
91,836,387
|
|
43,276,754
|
|
|
|
|
|
|
| Contractual term |
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
| Stock-based compensation expense (in Dollars) |
|
|
|
|
|
|
|
$ 8,116,678
|
$ 7,498,817
|
|
|
|
|
|
| Unrecognized total compensation cost (in Dollars) |
|
|
|
|
|
|
|
$ 7,814,682
|
|
|
|
|
|
|
| Unrecognized total compensation cost |
|
|
|
|
|
|
|
1 year 2 months 23 days
|
|
|
|
|
|
|
| Restricted stock awards |
|
|
11,600,000
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock awards date |
|
|
Sep. 19, 2028
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock on the date of grant (in Dollars) |
|
|
$ 20,300,000
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
|
|
|
5 years 29 days
|
|
|
|
|
|
|
| Common stock reserved |
|
|
|
|
|
46,836,387
|
|
13,276,754
|
|
|
|
|
|
|
| Warrants outstanding (in Dollars) |
|
|
|
|
|
|
|
$ 6,125,681
|
|
|
|
|
|
|
| Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of exercisable warrants |
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
$ 1.32
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
|
$ 8,197,000
|
|
|
|
|
|
|
|
|
|
| Warrant commencement date |
|
|
|
|
Jan. 17, 2026
|
|
|
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
|
3 years 5 months 8 days
|
|
|
|
|
|
|
|
|
| Common stock reserved |
|
|
|
|
|
46,836,387
|
|
|
|
|
|
|
|
|
| Warrants outstanding (in Dollars) |
|
|
|
|
|
$ 15,227,835
|
|
|
|
|
|
|
|
|
| Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
|
272,727
|
1,816,513
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
|
$ 1.65
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
$ 717,000
|
$ 905,000
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent fee |
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
| Warrant expire date |
|
|
|
|
Jul. 17, 2030
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent cash fee |
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
| Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
15,229,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.0899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate shares of common stock |
|
|
|
|
|
|
|
|
|
30,000,000
|
|
|
|
|
| Additional shares of common stock |
|
|
|
|
|
|
|
|
|
15,000,000
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
| Common stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
| Warrants purchase |
|
|
|
5,142,858
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 1.92
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds offering (in Dollars) |
|
|
|
|
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
$ 6,995,000
|
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent fee |
|
|
|
7.00%
|
7.00%
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent cash fee |
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering (in Dollars) |
|
|
|
|
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
| Common stock on the date of grant per share (in Dollars per share) |
|
|
$ 1.75
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
360,000
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 1.84
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering (in Dollars) |
|
|
|
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
205,714
|
477,273
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 2.1875
|
$ 1.65
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent fee |
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
| Expenses of placement agent fee (in Dollars) |
|
|
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
|
| Warrant commencement date |
|
|
|
Mar. 10, 2026
|
Aug. 17, 2025
|
|
|
|
|
|
|
|
|
|
| Warrant expire date |
|
|
|
Mar. 10, 2031
|
Jul. 17, 2030
|
|
|
|
|
|
|
|
|
|
| Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock authorized |
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
| Preferred stock par value (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
| September 2025 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
5,142,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
|
|
|
$ 7,619,854
|
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent fee |
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
| Expenses of placement agent fee (in Dollars) |
|
|
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
|
| Warrant commencement date |
|
|
|
Mar. 10, 2026
|
|
|
|
|
|
|
|
|
|
|
| Warrant expire date |
|
|
|
Mar. 10, 2031
|
|
|
|
|
|
|
|
|
|
|
| Common stock per share (in Dollars per share) |
|
|
|
$ 1.75
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering (in Dollars) |
|
|
|
$ 9,000,000
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.09
|
|
|
$ 1.84
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
$ 4,179,000
|
|
$ 6,995,000
|
|
|
|
|
|
|
|
|
|
|
| Warrant commencement date |
|
|
|
Mar. 10, 2026
|
|
|
|
|
|
|
|
|
|
|
| Warrant expire date |
|
|
|
Mar. 10, 2031
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
205,714
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 1.92
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
|
|
$ 717,000
|
|
|
|
|
|
|
|
|
|
|
| Warrant commencement date |
|
|
|
Mar. 10, 2026
|
|
|
|
|
|
|
|
|
|
|
| Warrant expire date |
|
|
|
Mar. 10, 2031
|
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent cash fee |
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
5,142,858
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
5,142,858
|
|
|
|
|
|
|
|
|
|
|
| September 2025 Offering [Member] | Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
360,000
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
|
|
|
$ 2.1875
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
16,513,762
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds (in Dollars) |
$ 15,125,489
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent fee |
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expenses of placement agent fee (in Dollars) |
$ 135,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering (in Dollars) |
$ 18,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Term of exercisable warrants |
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant expire date |
Dec. 08, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
1,155,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
$ 1,401,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant expire date |
Dec. 08, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of placement agent cash fee |
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
15,229,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
15,229,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants exercisable |
15,229,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Investors Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
16,513,762
|
|
|
|
|
16,513,762
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
$ 13,196,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
1,284,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
1,284,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
660,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.3625
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| December 2025 Offering [Member] | Common Stock [Member] | Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.0899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Award [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense (in Dollars) |
|
|
|
|
|
$ 1,704,015
|
|
$ 203,741
|
|
|
|
|
|
|
| Restricted stock awards date |
|
|
Sep. 19, 2028
|
|
|
|
|
|
|
|
|
|
|
|
| Unrecognized total compensation cost related to unvested restricted stock awards (in Dollars) |
|
|
|
|
|
$ 18,392,245
|
|
$ 20,096,259
|
|
|
|
|
|
|
| Weighted average period |
|
|
|
|
|
2 years 8 months 19 days
|
|
2 years 11 months 19 days
|
|
|
|
|
|
|
| Restricted Stock Award [Member] | Board of Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock awards |
|
|
11,600,000
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Award [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock on the date of grant (in Dollars) |
|
|
$ 20,300,000
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock on the date of grant per share (in Dollars per share) |
|
|
$ 1.75
|
|
|
|
|
|
|
|
|
|
|
|
| Investor [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of the warrants (in Dollars) |
|
$ 5,301,000
|
|
|
$ 8,197,000
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contractual term |
|
|
|
|
|
|
|
12 months
|
|
|
|
|
|
|
| Minimum [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
100,000,000
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contractual term |
|
|
|
|
|
|
|
36 months
|
|
|
|
|
|
|
| Maximum [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock authorized |
|
|
|
|
|
|
|
|
|
|
400,000,000
|
|
|
400,000,000
|
| IPO [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
6,818,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share (in Dollars per share) |
$ 1.09
|
|
|
|
$ 1.09
|
|
|
|
|
|
|
|
|
|
| IPO [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of common stock |
|
|
|
|
6,818,182
|
|
|
|
|
|
|
|
|
|
| Warrants purchase |
|
|
|
|
6,818,182
|
|
|
|
|
|
|
|
|
|
| Common stock price per share (in Dollars per share) |
|
|
|
|
$ 1.32
|
|
|
|
|
|
|
|
|
|
| IPO [Member] | Common Stock [Member] | Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock price per share (in Dollars per share) |
|
|
|
|
$ 1.09
|
|
|
|
|
|
|
|
|
|
| Stock Plans [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder’s Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000
|
15,000,000
|
| Contractual term |
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense (in Dollars) |
|
|
|
|
|
$ 2,252,035
|
$ 1,808,478
|
|
|
|
|
|
|
|
| Unrecognized total compensation cost (in Dollars) |
|
|
|
|
|
$ 5,562,647
|
|
|
|
|
|
|
|
|
| Unrecognized total compensation cost |
|
|
|
|
|
1 year 29 days
|
|
|
|
|
|
|
|
|